Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pituitary Neoplasms 2Dwarfism, Pituitary 2Pituitary Diseases 1Metabolic Syndrome 1Hypopituitarism 1Atherosclerosis 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Human Growth Hormone × Endocrine × Clear all
NCT00136032 2008-02-18

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Massachusetts General Hospital

Phase NA Completed
63 enrolled
Endocrine

Dwarfism, Pituitary, Pituitary Diseases, Pituitary Neoplasms

NCT00462475 2007-10-16

5yrGH

Federico II University

Completed
20 enrolled
Endocrine

Dwarfism, Pituitary, Hypopituitarism, Pituitary Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡